Literature DB >> 27217706

Lymph node dissection in esophageal carcinoma: Minimally invasive esophagectomy vs open surgery.

Bo Ye1, Chen-Xi Zhong1, Yu Yang1, Wen-Tao Fang1, Teng Mao1, Chun-Yu Ji1, Zhi-Gang Li1.   

Abstract

AIM: To compare lymph node dissection results of minimally invasive esophagectomy (MIE) and open surgery for esophageal squamous cell carcinoma.
METHODS: We retrospectively reviewed data from patients who underwent MIE or open surgery for esophageal squamous cell carcinoma from January 2011 to September 2014. Number of lymph nodes resected, positive lymph node (pN+) rate, lymph node sampling (LNS) rate and lymph node metastatic (LNM) rate were evaluated.
RESULTS: Among 447 patients included, 123 underwent MIE and 324 underwent open surgery. The number of lymph nodes resected did not significantly differ between the MIE and open surgery groups (21.1 ± 4.3 vs 20.4 ± 3.8, respectively, P = 0.0944). The pN+ rate of stage T3 esophageal squamous cell carcinoma in the open surgery group was higher than that in the MIE group (16.3% vs 11.4%, P = 0.031), but no differences was observed for stages T1 and T2 esophageal squamous cell carcinoma. The LNS rate at left para-recurrent laryngeal nerve (RLN) site was significantly higher for open surgery than for MIE (80.2% vs 43.9%, P < 0.001), but no differences were noted at other sites. The LNM rate at left para-RLN site in the open surgery group was significantly higher than that in the MIE group, regardless of pathologic T stage.
CONCLUSION: For stages T1 and T2 esophageal squamous cell carcinoma, the lymph node dissection result after MIE was comparable to that achieved by open surgery. However, the efficacy of MIE in lymphadenectomy for stage T3 esophageal squamous cell carcinoma, particularly at left para-RLN site, remains to be improved.

Entities:  

Keywords:  Esophageal cancer; Lymph node; Minimally invasive; Surgery

Mesh:

Year:  2016        PMID: 27217706      PMCID: PMC4870081          DOI: 10.3748/wjg.v22.i19.4750

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

Review 1.  Laparoscopic and thoracoscopic esophagectomy.

Authors:  Ryan M Levy; Joseph Wizorek; Manisha Shende; James D Luketich
Journal:  Adv Surg       Date:  2010

2.  Omentoplasty in preventing anastomotic leakage of oesophagogastrostomy following radical oesophagectomy with three-field lymphadenectomy.

Authors:  Qing-Feng Zheng; Jian-Jun Wang; Min-Gang Ying; Shou-Yan Liu
Journal:  Eur J Cardiothorac Surg       Date:  2012-05-30       Impact factor: 4.191

Review 3.  Minimally invasive esophagectomy: an overview.

Authors:  B Mark Smithers
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-02       Impact factor: 3.869

4.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Omar Khan; Shiyam Nizar; Georgios Vasilikostas; Andrew Wan
Journal:  J Thorac Dis       Date:  2012-10       Impact factor: 2.895

5.  Comparison of perioperative outcomes following open versus minimally invasive Ivor Lewis oesophagectomy at a single, high-volume centre.

Authors:  Smita Sihag; Cameron D Wright; John C Wain; Henning A Gaissert; Michael Lanuti; James S Allan; Douglas J Mathisen; Christopher R Morse
Journal:  Eur J Cardiothorac Surg       Date:  2012-02-15       Impact factor: 4.191

6.  The use of a tailored surgical technique for minimally invasive esophagectomy.

Authors:  Jeffrey Javidfar; Matthew Bacchetta; Jonathan A Yang; Joanna Miller; Frank D'Ovidio; Mark E Ginsburg; Lyall A Gorenstein; Marc Bessler; Joshua R Sonett
Journal:  J Thorac Cardiovasc Surg       Date:  2012-05       Impact factor: 5.209

7.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

8.  Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study.

Authors:  James D Luketich; Arjun Pennathur; Yoko Franchetti; Paul J Catalano; Scott Swanson; David J Sugarbaker; Alberto De Hoyos; Michael A Maddaus; Ninh T Nguyen; Al B Benson; Hiran C Fernando
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

9.  Radical lymph node dissection for cancer of the thoracic esophagus.

Authors:  H Akiyama; M Tsurumaru; H Udagawa; Y Kajiyama
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

10.  Cervical, mediastinal, and abdominal lymph node dissection (three-field dissection) for superficial carcinoma of the thoracic esophagus.

Authors:  H Kato; Y Tachimori; S Mizobuchi; H Igaki; A Ochiai
Journal:  Cancer       Date:  1993-11-15       Impact factor: 6.860

View more
  8 in total

Review 1.  Chinese expert consensus on mediastinal lymph node dissection in esophagectomy for esophageal cancer (2017 edition).

Authors:  Hui Li; Wentao Fang; Zhentao Yu; Yousheng Mao; Longqi Chen; Jie He; Tiehua Rong; Chun Chen; Haiquan Chen; Keneng Chen; Ming Du; Yongtao Han; Jian Hu; Jianhua Fu; Xiaobin Hou; Taiqian Gong; Yin Li; Junfeng Liu; Shuoyan Liu; Lijie Tan; Hui Tian; Qun Wang; Jiaqing Xiang; Meiqing Xu; Xin Ye; Bin You; Renquan Zhang; Yan Zhao
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

2.  Minimally invasive esophagectomy for esophageal squamous cell carcinoma-Shanghai Chest Hospital experience.

Authors:  Bin Li; Yu Yang; Yifeng Sun; Rong Hua; Xiaobin Zhang; Xufeng Guo; Haiyong Gu; Bo Ye; Zhigang Li; Teng Mao
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Recurrent laryngeal nerve lymph node dissection in minimally invasive esophagectomy.

Authors:  Miao Lin; Yaxing Shen; Hao Wang; Mingxiang Feng; Lijie Tan
Journal:  J Vis Surg       Date:  2016-10-20

4.  Adjuvant therapy for pathological T3N0M0 esophageal squamous cell carcinoma.

Authors:  Xiaobin Zhang; Yu Yang; Yifeng Sun; Bo Ye; Xufeng Guo; Teng Mao; Rong Hua; Bin Li; Haiyong Gu; Jun Liu; Zhigang Li
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

5.  Minimally invasive esophagectomy is a safe surgical treatment for locally advanced pathologic T3 esophageal squamous cell carcinoma.

Authors:  Xiaobin Zhang; Yu Yang; Bo Ye; Yifeng Sun; Xufeng Guo; Rong Hua; Teng Mao; Wentao Fang; Zhigang Li
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

6.  Robot assisted esophagectomy for esophageal squamous cell carcinoma.

Authors:  Xiaobin Zhang; Yuchen Su; Yu Yang; Yifeng Sun; Bo Ye; Xufeng Guo; Teng Mao; Rong Hua; Zhigang Li
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

7.  Risk factors for lymph node metastasis of the left recurrent laryngeal nerve in patients with esophageal squamous cell carcinoma.

Authors:  Chuangui Chen; Zhao Ma; Xiaobin Shang; Xiaofeng Duan; Jie Yue; Hongjing Jiang
Journal:  Ann Transl Med       Date:  2021-03

Review 8.  Minimally invasive techniques for transthoracic oesophagectomy for oesophageal cancer: systematic review and network meta-analysis.

Authors:  K Siaw-Acheampong; S K Kamarajah; R Gujjuri; J R Bundred; P Singh; E A Griffiths
Journal:  BJS Open       Date:  2020-09-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.